Putnam Investments LLC Next Cure, Inc. Transaction History

Putnam Investments LLC

  • $73 Billion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$32.32 - $58.37 $2.79 Million - $5.04 Million
-86,300 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$25.0 - $92.22 $1.51 Million - $5.57 Million
60,400 Added 233.2%
86,300 $4.86 Million
Q3 2019

Nov 14, 2019
BUY
$15.73 - $41.6 $407,407 - $1.08 Million
25,900 New
25,900 $799,000

Others Institutions Holding NXTC

# of Institutions
45
Shares Held
17.4M
Call Options Held
0
Put Options Held
0
View Full List

About NextCure, Inc.

NXTC Quotes by TradingView
  • Ticker NXTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,748,800
  • Market Cap $21.1M
  • Description
  • NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...
More about NXTC
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email